Insightec, a company making an ultrasound device that can be used to treat essential tremor, raised $150 million. The company now has a post-money valuation of $1.3 billion.
After it received expanded FDA approval for an incisionless surgical device, Insightec raised new funding that valued the company above $1 billion.
The company closed a $150 million funding round for its surgical ultrasound device, used to treat essential tremor in patients that haven’t responded to medication, and tremor-dominant Parkinson’s disease. Koch Disruptive Technologies, a subsidiary of Koch, Inc., led the funding round, bringing Insightec’s post-money valuation to $1.3 billion.
